| [1] |
American Cancer Society.Cancer facts and figures 2008[R].Atlanta：American Cancer Society,2008.
|
| [2] |
Mitchell I，Livingston EH,Chang AY,et al．Trends in thyroid cancer demographics and surgical therapy in the United States[J].Surgery,2007,42(6)：823-8．
|
| [3] |
Ji B,Wang GY,Zhang P,et al.Relationship between COX-2 and VEGF expression in thyroid cancer and angiogenesis and clinical pathology [J].Jilin Da Xue Xue Bao(Yi Xue Ban),2006,32(6)：1077-80.[纪柏， 王广义，张平，等．甲状腺癌COX-2和VEGF的表达与血管生成及临床病理的关系[J]．吉林大学学报(医学版)，2006 ，32(6)：1077- 80.]
|
| [4] |
Fenton C,Patel A,Dinauer C,et al.The Expression of Vascular Endothelial Growth Factor and the Type 1 Vascular Endothelial Growth Factor Receptor Correlate with the Size of Papillary Thyroid Carcinoma in Children and Young Adults[J]，Thyroid，2000,10(4):349-57.
|
| [5] |
Klein M,Vignaud JM,Hennequin V,et al.Increased expression of the vascular endothelial growth factor is a pejorative prognosis marker in papillary thyroid carcinoma [J].J Clin Endocrinol Metab,2001,86(2):656-8.
|
| [6] |
Lennard CM,Patel A,Wilson J,et al.Intensity of vascular endothelial growth factor expression is associated with increased risk of recurrence and decreased disease-free survival in papillary thyroid cancer[J].Surgery,2001,129(5):552-8.
|
| [7] |
Boelaert K,Horacek J,Holder RL,et al.Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine- needle aspiration[J].J Clin Endocrinol Metab,2006,91(11):4295-301.
|
| [8] |
Haymart MR,Repplinger DJ,Leverson GE,et al.Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage[J].J Clin Endocrinol Metab,2008,93(3):809-14.
|
| [9] |
Shi LF,Guan HX,Li YS,et al.The relationship between Preoperative serum thyroid-stimulating hormone level and thyroid nodule [J].Zhonghua Nei Fen Mi Dai Xie Za Zhi,2010,26(3):213-4.[史良凤,关 海霞,李玉姝,等.术前血清促甲状腺素水平与甲状腺结节良恶性关系的研究[J].中华内分泌代谢杂志,2010,26 (3):213-4.]
|
| [10] |
Ma Junfeng,Tang Bo,Li Tiehan,et al.Value of thyroid stimulating hormone inhibition therapy in differentiated thyroid carcinoma[J].Zhongguo Pu Wai Ji Chu Yu Lin Chuang Za Zhi,2009,16(5):348-55.[ 马峻峰，唐波，李铁汉，等．促甲状腺激素抑制疗法在分化型甲状腺癌治疗中的作用[J].中国普外基础与临床杂志 ，2009，16(5)：348-55]．
|
| [11] |
Li JZ,Liu X,Zhang LY,et al.Relationship between preoperative serum TSH concentrations and differentiated thyroid cancer [J].Shandong Da Xue Xue Bao (Yi Xue Ban),2011,49 (1)：10 -3 [李建周， 刘欣，张凌云，等.术前血清TSH浓度与分化型甲状腺癌的相关性研究[J].山东大学学报(医学版),2011,49(1):10- 3].
|
| [12] |
Hoelting T，Goretzki PE，Duh QY．Follicular thyroid cancer cells：a model of metastatic tumor in vitro(review)[J].Oncol Rep,2001,8(1):3-8.
|
| [13] |
Hoffmann S,Hofbauer LC，Scharrenbach V，et al.Thyrotropin (TSH)-induced production of vascular endothelial growth factor in thyroid cancer cells in vitro evaluation of TSH signal transduction and of angiogenesis-stimulating growth factors[J].J Clin Endocrinol Metab,2004,89(12):6139-45.
|
下载:
